Janez Jazbec1, Patricija Ećimović, Berta Jereb. 1. Department of Pediatrics, Division of Oncology and Hematology, University Medical Centre Ljubljana, Ljubljana, Slovenia. Janez.Jazbec@mf.uni-lj.si
Abstract
BACKGROUND: The number of long time survivors of childhood cancer treatment is constantly increasing over the last decades as a result of advances in diagnosis and treatment. The occurrence of second neoplasms is one of most serious late effects observed in cancer survivors. METHODS: The risk of secondary neoplasm was studied in a cohort of 1,577 patients treated for childhood cancer registered in the Cancer Registry of Slovenia (CRS) between 1961 and 2000. The time at risk was defined from the date of diagnosis of first malignancy to the time of death or the end of the study. RESULTS: The most frequent primary malignancies were: acute leukemia 28.5%, central nervous system (CNS) tumors 21.3%, and lymphomas 16.6%. Median observation time was 7.8 years. Forty-eight patients developed second neoplasms. CNS tumors, acute leukemias, and thyroid carcinoma were most frequent second neoplasms. The cumulative risk for second neoplasm in the entire cohort was 0.06% at 5 years, 5.1% at 15 years, and 12.6% at 25 years after diagnosis of first cancer. The overall survival after second neoplasm was 65% 10 years after the diagnosis of second neoplasm. CONCLUSIONS: Patients after treatment of childhood cancer are at special risk for subsequent neoplasms and long-term follow-up is mandatory. Copyright 2004 Wiley-Liss, Inc.
BACKGROUND: The number of long time survivors of childhood cancer treatment is constantly increasing over the last decades as a result of advances in diagnosis and treatment. The occurrence of second neoplasms is one of most serious late effects observed in cancer survivors. METHODS: The risk of secondary neoplasm was studied in a cohort of 1,577 patients treated for childhood cancer registered in the Cancer Registry of Slovenia (CRS) between 1961 and 2000. The time at risk was defined from the date of diagnosis of first malignancy to the time of death or the end of the study. RESULTS: The most frequent primary malignancies were: acute leukemia 28.5%, central nervous system (CNS) tumors 21.3%, and lymphomas 16.6%. Median observation time was 7.8 years. Forty-eight patients developed second neoplasms. CNS tumors, acute leukemias, and thyroid carcinoma were most frequent second neoplasms. The cumulative risk for second neoplasm in the entire cohort was 0.06% at 5 years, 5.1% at 15 years, and 12.6% at 25 years after diagnosis of first cancer. The overall survival after second neoplasm was 65% 10 years after the diagnosis of second neoplasm. CONCLUSIONS:Patients after treatment of childhood cancer are at special risk for subsequent neoplasms and long-term follow-up is mandatory. Copyright 2004 Wiley-Liss, Inc.
Authors: Nina Erčulj; Barbara Faganel Kotnik; Maruša Debeljak; Janez Jazbec; Vita Dolžan Journal: J Cancer Res Clin Oncol Date: 2012-07-01 Impact factor: 4.553
Authors: María Sol Brassesco; Danilo Jordão Xavier; Marjori Leiva Camparoto; Ana Paula Montaldi; Paulo Roberto D'Auria Vieira de Godoy; Carlos Alberto Scrideli; Luiz Gonzaga Tone; Elza Tiemi Sakamoto-Hojo Journal: J Biomed Biotechnol Date: 2010-08-31
Authors: Kyle Strodtbeck; Andrew Sloan; Lisa Rogers; Paul Graham Fisher; Duncan Stearns; Laura Campbell; Jill Barnholtz-Sloan Journal: J Neurooncol Date: 2013-02-08 Impact factor: 4.130
Authors: M M Fidler; C Frobisher; J Guha; K Wong; J Kelly; D L Winter; E Sugden; R Duncan; J Whelan; R C Reulen; M M Hawkins Journal: Br J Cancer Date: 2015-05-19 Impact factor: 7.640